[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100495563":3},{"organization":4,"armGroups":7,"interventions":39,"overallOfficials":52,"centralContacts":56,"locations":61,"responsibleParty":379,"collaborators":45,"id":381,"slug":382,"hasResults":383,"nctId":384,"briefTitle":385,"officialTitle":386,"acronym":45,"eligibilityCriteria":387,"healthyVolunteers":383,"sex":388,"minAge":389,"maxAge":45,"enrollmentInfo":390,"targetDuration":45,"studyType":393,"phases":394,"briefSummary":397,"conditions":398,"keywords":400,"overallStatus":64,"whyStopped":45,"lastUpdateSubmitDate":415,"lastUpdatePostDateStruct":416,"startDateStruct":419,"completionDateStruct":421,"leadSponsor":423,"locationsCount":424},{"fullName":5,"class":6},"Tango Therapeutics, Inc.","INDUSTRY",[8,15,19,23,27,31,35],{"label":9,"type":10,"description":11,"interventionNames":12},"Dose Escalation","EXPERIMENTAL","Participants with MTAP-deleted solid tumors (excluding primary CNS) will receive escalating doses of TNG462 single agent and in combination with pembrolizumab to estimate the MTD",[13,14],"Drug: TNG462","Drug: Pembrolizumab",{"label":16,"type":10,"description":17,"interventionNames":18},"Dose Expansion in NSCLC","Participants with MTAP-deleted NSCLC (squamous and non squamous) will receive TNG462 at the identified RP2D(s)",[13],{"label":20,"type":10,"description":21,"interventionNames":22},"Dose Expansion in Mesothelioma","Participants with MTAP-deleted mesothelioma will receive TNG462 at the identified RP2D(s)",[13],{"label":24,"type":10,"description":25,"interventionNames":26},"Dose Expansion in Pancreatic Ductal Adenocarcinoma","Participants with MTAP-deleted pancreatic ductal adenocarcinoma will receive TNG462 at the identified RP2D(s)",[13],{"label":28,"type":10,"description":29,"interventionNames":30},"Dose Expansion in Sarcoma","Participants with MTAP-deleted sarcoma (soft tissue or bone) will receive TNG462 at the identified RP2D(s)",[13],{"label":32,"type":10,"description":33,"interventionNames":34},"Dose Expansion in Solid Tumors","Participants with other MTAP-deleted solid tumors will receive TNG462 at the identified RP2D(s)",[13],{"label":36,"type":10,"description":37,"interventionNames":38},"Dose Expansion in NSCLC in Combination with Pembrolizumab","Participants NSCLC (squamous and non squamous) MTAP-deleted solid tumors will receive TNG462 at the identified RP2D(s)",[13,14],[40,46],{"type":41,"name":42,"description":43,"armGroupLabels":44,"otherNames":45},"DRUG","TNG462","TNG462, a selective PRMT5 inhibitor, will be administered orally",[9,20,16,36,24,28,32],null,{"type":41,"name":47,"description":48,"armGroupLabels":49,"otherNames":50},"Pembrolizumab","An anti PD-1 antibody, will be administered intravenously",[9,36],[51],"Keytruda",[53],{"name":54,"affiliation":5,"role":55},"Maxim Pimpkin, MD","STUDY_DIRECTOR",[57],{"name":54,"role":58,"phone":59,"phoneExt":45,"email":60},"CONTACT","(857) 320-4899","clinicaltrials@tangotx.com",[62,80,93,104,116,129,141,153,166,175,188,200,213,226,239,252,266,278,290,302,316,325,334,346,355,367],{"facility":63,"status":64,"city":65,"state":66,"zip":67,"country":68,"countryCode":69,"cosmosGeoPoint":70,"geoPoint":75,"contacts":76},"Stanford University","RECRUITING","Palo Alto","California","94304","United States","US",{"type":71,"coordinates":72},"Point",[73,74],-122.14302,37.44188,{"lat":74,"lon":73},[77],{"name":78,"role":79,"phone":45,"phoneExt":45,"email":45},"Christopher Chen","PRINCIPAL_INVESTIGATOR",{"facility":81,"status":64,"city":82,"state":83,"zip":84,"country":68,"countryCode":69,"cosmosGeoPoint":85,"geoPoint":89,"contacts":90},"Grand Valley Oncology","Grand Junction","Colorado","81505",{"type":71,"coordinates":86},[87,88],-108.55065,39.06387,{"lat":88,"lon":87},[91],{"name":92,"role":79,"phone":45,"phoneExt":45,"email":45},"Jonathan King, MD",{"facility":94,"status":95,"city":96,"state":97,"zip":98,"country":68,"countryCode":69,"cosmosGeoPoint":99,"geoPoint":103,"contacts":45},"Florida Cancer Specialists & Research Institute","COMPLETED","Lake Mary","Florida","32746",{"type":71,"coordinates":100},[101,102],-81.31784,28.75888,{"lat":102,"lon":101},{"facility":105,"status":64,"city":106,"state":97,"zip":107,"country":68,"countryCode":69,"cosmosGeoPoint":108,"geoPoint":112,"contacts":113},"Sylvester Comprehensive Cancer Center","Miami","33136",{"type":71,"coordinates":109},[110,111],-80.19366,25.77427,{"lat":111,"lon":110},[114],{"name":115,"role":79,"phone":45,"phoneExt":45,"email":45},"Jose Lutzky, MD",{"facility":117,"status":64,"city":118,"state":119,"zip":120,"country":68,"countryCode":69,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"University Chicago Medicine","Chicago","Illinois","60637",{"type":71,"coordinates":122},[123,124],-87.65005,41.85003,{"lat":124,"lon":123},[127],{"name":128,"role":79,"phone":45,"phoneExt":45,"email":45},"Hedy Kindler, MD",{"facility":130,"status":64,"city":131,"state":119,"zip":132,"country":68,"countryCode":69,"cosmosGeoPoint":133,"geoPoint":137,"contacts":138},"Carle Cancer Center","Urbana","61801",{"type":71,"coordinates":134},[135,136],-88.20727,40.11059,{"lat":136,"lon":135},[139],{"name":140,"role":79,"phone":45,"phoneExt":45,"email":45},"Tammay Sahai, MD",{"facility":142,"status":64,"city":143,"state":119,"zip":144,"country":68,"countryCode":69,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"Midwestern Regional Medical Center, City of Hope Chicago","Zion","60099",{"type":71,"coordinates":146},[147,148],-87.83285,42.44613,{"lat":148,"lon":147},[151],{"name":152,"role":79,"phone":45,"phoneExt":45,"email":45},"Evan Pisick, MD",{"facility":154,"status":64,"city":155,"state":156,"zip":157,"country":68,"countryCode":69,"cosmosGeoPoint":158,"geoPoint":162,"contacts":163},"Massachusetts General Hospital","Boston","Massachusetts","02214",{"type":71,"coordinates":159},[160,161],-71.05977,42.35843,{"lat":161,"lon":160},[164],{"name":165,"role":79,"phone":45,"phoneExt":45,"email":45},"Ibiayi Dagogo-Jack, MD",{"facility":167,"status":64,"city":155,"state":156,"zip":168,"country":68,"countryCode":69,"cosmosGeoPoint":169,"geoPoint":171,"contacts":172},"Dana Farber Cancer Institute","02215",{"type":71,"coordinates":170},[160,161],{"lat":161,"lon":160},[173],{"name":174,"role":79,"phone":45,"phoneExt":45,"email":45},"Candace Haddox, MD",{"facility":176,"status":64,"city":177,"state":178,"zip":179,"country":68,"countryCode":69,"cosmosGeoPoint":180,"geoPoint":184,"contacts":185},"Henry Ford Cancer Center","Detroit","Michigan","48202",{"type":71,"coordinates":181},[182,183],-83.04575,42.33143,{"lat":183,"lon":182},[186],{"name":187,"role":79,"phone":45,"phoneExt":45,"email":45},"Amy Weise, DO",{"facility":189,"status":64,"city":190,"state":190,"zip":191,"country":68,"countryCode":69,"cosmosGeoPoint":192,"geoPoint":196,"contacts":197},"New York University Langone Health","New York","10016",{"type":71,"coordinates":193},[194,195],-74.00597,40.71427,{"lat":195,"lon":194},[198],{"name":199,"role":79,"phone":45,"phoneExt":45,"email":45},"Salman Punekar, MD",{"facility":201,"status":64,"city":202,"state":203,"zip":204,"country":68,"countryCode":69,"cosmosGeoPoint":205,"geoPoint":209,"contacts":210},"Sarah Cannon Tennessee Oncology","Nashville","Tennessee","37203",{"type":71,"coordinates":206},[207,208],-86.78444,36.16589,{"lat":208,"lon":207},[211],{"name":212,"role":79,"phone":45,"phoneExt":45,"email":45},"David Spigel, MD",{"facility":214,"status":64,"city":215,"state":216,"zip":217,"country":68,"countryCode":69,"cosmosGeoPoint":218,"geoPoint":222,"contacts":223},"The University of Texas MD Anderson Cancer Center","Houston","Texas","77030",{"type":71,"coordinates":219},[220,221],-95.36327,29.76328,{"lat":221,"lon":220},[224],{"name":225,"role":79,"phone":45,"phoneExt":45,"email":45},"Jordi Rodon Ahnert, MD",{"facility":227,"status":64,"city":228,"state":229,"zip":230,"country":68,"countryCode":69,"cosmosGeoPoint":231,"geoPoint":235,"contacts":236},"Huntsman Cancer Institute, University of Utah","Salt Lake City","Utah","84112",{"type":71,"coordinates":232},[233,234],-111.89105,40.76078,{"lat":234,"lon":233},[237],{"name":238,"role":79,"phone":45,"phoneExt":45,"email":45},"Vaia Florou, MD, MS",{"facility":240,"status":64,"city":241,"state":242,"zip":243,"country":68,"countryCode":69,"cosmosGeoPoint":244,"geoPoint":248,"contacts":249},"Next Oncology Virginia","Fairfax","Virginia","22031",{"type":71,"coordinates":245},[246,247],-77.30637,38.84622,{"lat":247,"lon":246},[250],{"name":251,"role":79,"phone":45,"phoneExt":45,"email":45},"Alexander Spira, MD, PhD",{"facility":253,"status":64,"city":254,"state":45,"zip":255,"country":256,"countryCode":257,"cosmosGeoPoint":258,"geoPoint":262,"contacts":263},"CHU de Brest","Brest","29200","France","FR",{"type":71,"coordinates":259},[260,261],-4.48628,48.39029,{"lat":261,"lon":260},[264],{"name":265,"role":79,"phone":45,"phoneExt":45,"email":45},"Jean-Philippe Metges, MD",{"facility":267,"status":64,"city":268,"state":45,"zip":269,"country":256,"countryCode":257,"cosmosGeoPoint":270,"geoPoint":274,"contacts":275},"Centre Berard Leon","Lyon","69373",{"type":71,"coordinates":271},[272,273],4.84789,45.74906,{"lat":273,"lon":272},[276],{"name":277,"role":79,"phone":45,"phoneExt":45,"email":45},"Philippe Cassier, MD",{"facility":279,"status":64,"city":280,"state":45,"zip":281,"country":256,"countryCode":257,"cosmosGeoPoint":282,"geoPoint":286,"contacts":287},"Institut de Cancerologie de l'Ouest - Hôpital Saint Herblain - PPDS","Saint-Herblain","44805",{"type":71,"coordinates":283},[284,285],-1.651,47.21154,{"lat":285,"lon":284},[288],{"name":289,"role":79,"phone":45,"phoneExt":45,"email":45},"Ludovic Doucet, MD, MSc",{"facility":291,"status":64,"city":292,"state":45,"zip":293,"country":256,"countryCode":257,"cosmosGeoPoint":294,"geoPoint":298,"contacts":299},"Institute Gustav Roussy","Villejuif","94805",{"type":71,"coordinates":295},[296,297],2.35992,48.7939,{"lat":297,"lon":296},[300],{"name":301,"role":79,"phone":45,"phoneExt":45,"email":45},"Kaissa Ouali, MD",{"facility":303,"status":64,"city":304,"state":305,"zip":45,"country":306,"countryCode":307,"cosmosGeoPoint":308,"geoPoint":312,"contacts":313},"Vall d'Hebron Barcelona Hospital","Barcelona","Catalonia","Spain","ES",{"type":71,"coordinates":309},[310,311],2.15899,41.38879,{"lat":311,"lon":310},[314],{"name":315,"role":79,"phone":45,"phoneExt":45,"email":45},"Irene Brana, MD",{"facility":317,"status":64,"city":304,"state":45,"zip":318,"country":306,"countryCode":307,"cosmosGeoPoint":319,"geoPoint":321,"contacts":322},"Hospital HM Nou Delfos","08023",{"type":71,"coordinates":320},[310,311],{"lat":311,"lon":310},[323],{"name":324,"role":79,"phone":45,"phoneExt":45,"email":45},"Tatiana Hernandez Guerrero, MD",{"facility":326,"status":64,"city":304,"state":45,"zip":327,"country":306,"countryCode":307,"cosmosGeoPoint":328,"geoPoint":330,"contacts":331},"ICO l'Hospitalet - Hospital Duran i Reynals","08908",{"type":71,"coordinates":329},[310,311],{"lat":311,"lon":310},[332],{"name":333,"role":79,"phone":45,"phoneExt":45,"email":45},"Mariona Calvo Campos, MD",{"facility":335,"status":64,"city":336,"state":45,"zip":337,"country":306,"countryCode":307,"cosmosGeoPoint":338,"geoPoint":342,"contacts":343},"Hospital Universitario Fundacion Jimenez Diaz","Madrid","28040",{"type":71,"coordinates":339},[340,341],-3.70256,40.4165,{"lat":341,"lon":340},[344],{"name":345,"role":79,"phone":45,"phoneExt":45,"email":45},"Victor Moreno Garcia, MD",{"facility":347,"status":64,"city":336,"state":45,"zip":348,"country":306,"countryCode":307,"cosmosGeoPoint":349,"geoPoint":351,"contacts":352},"Hospital de Sanchinarro","28050",{"type":71,"coordinates":350},[340,341],{"lat":341,"lon":340},[353],{"name":354,"role":79,"phone":45,"phoneExt":45,"email":45},"Emiliano Calvo Aller, MD",{"facility":356,"status":64,"city":357,"state":45,"zip":358,"country":306,"countryCode":307,"cosmosGeoPoint":359,"geoPoint":363,"contacts":364},"Hospital Universitario Virgen de la Victoria","Málaga","29010",{"type":71,"coordinates":360},[361,362],-4.42034,36.72016,{"lat":362,"lon":361},[365],{"name":366,"role":79,"phone":45,"phoneExt":45,"email":45},"Javier Garcia-Corbacho, MD",{"facility":368,"status":64,"city":369,"state":45,"zip":370,"country":306,"countryCode":307,"cosmosGeoPoint":371,"geoPoint":375,"contacts":376},"Hospital Universitario Virgen del Rocio","Seville","41013",{"type":71,"coordinates":372},[373,374],-5.97317,37.38283,{"lat":374,"lon":373},[377],{"name":378,"role":79,"phone":45,"phoneExt":45,"email":45},"Alejandro Falcon, MD",{"type":380,"investigatorFullName":45,"investigatorTitle":45,"investigatorAffiliation":45,"oldNameTitle":45,"oldOrganization":45},"SPONSOR","100495563","phase-1-safety-and-tolerability-of-tng462-in-patients-with-mtap-deleted-solid-tumors-100495563",false,"NCT05732831","Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors","A Phase 1\u002F2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG462 as a Single Agent and in Combination in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors","Inclusion Criteria:\n\n1. Age: ≥18 years-of-age at the time of signature of the main study ICF\n2. Performance status: ECOG Performance Score of 0 to 1\n3. Confirmed histologic or cytologic diagnosis of a locally advanced, metastatic, and\u002For unresectable solid tumor\n4. Prior standard therapy, as available\n5. Documented bi-allelic (homozygous) deletion of MTAP in a tumor detected by next- generation sequencing or absence of MTAP protein in a tumor detected by IHC.\n6. Adequate organ function\u002Freserve per local labs\n7. Adequate liver function per local labs\n8. Adequate renal function per local labs\n9. Negative serum pregnancy test result at screening\n10. Written informed consent must be obtained according to local guidelines\n\nExclusion Criteria:\n\n1. Known allergies, hypersensitivity, or intolerance to TNG462, or its excipients or to pembrolizumab in the combination treatment arms\n2. Uncontrolled intercurrent illness that will limit compliance with the study requirements\n3. Active infection requiring systemic therapy\n4. Currently participating in or has planned participation in a study of another investigational agent or device\n5. Impairment of GI function or disease that may significantly alter the absorption of oral TNG462\n6. Active prior or concurrent malignancy.\n7. Central nervous system metastases associated with progressive neurological symptoms\n8. Current active liver disease from any cause\n9. Known to be HIV positive, unless all of the following criteria are met:\n\n   1. CD4+ count ≥300\u002FμL\n   2. Undetectable viral load\n   3. Receiving highly active antiretroviral therapy\n10. Clinically relevant cardiovascular disease\n11. A female patient who is pregnant or lactating\n12. Patient is unwilling or unable to comply with the scheduled visits, drug administration plan, laboratory tests, biopsy, or other study procedures and study restrictions\n13. Patient has a prior or ongoing clinically significant illness, medical condition, surgical history, physical finding, or laboratory abnormality that, in the investigator's opinion, may affect the safety of the patient or impair the assessment of study results","ALL","18 Years",{"count":391,"type":392},225,"ESTIMATED","INTERVENTIONAL",[395,396],"PHASE1","PHASE2","This is a first in human study in patients with advanced or metastatic solid tumors known to have an MTAP deletion. The first part of the study is an open-label, dose escalation and the second part is an open label dose expansion in specific MTAP-deleted tumor types. The study drug, TNG462, is a selective PRMT5 inhibitor administered orally. The study is planned to treat up to 225 participants.",[399],"Locally Advanced Solid Tumor",[401,402,403,404,405,406,407,408,409,410,411,412,413,414],"MTAP deletion","PRMT5","cholangiocarcinoma","NSCLC","mesothelioma","MPNST","Tango","pancreatic","sarcoma","urothelial","gallbladder","liver","renal","breast","2026-04-17",{"date":417,"type":418},"2026-04-21","ACTUAL",{"date":420,"type":418},"2023-05-26",{"date":422,"type":392},"2026-09",{"name":5,"class":6},26]